GeneReach Biotechnology Corp. (4171.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
About GeneReach Biotechnology Corp.
—
GeneReach Biotechnology Corp. is led by CEO De Yu Zhong, employs 120 people, headquartered in Taichung, TW, publicly traded since 2012.
GeneReach Biotechnology Corp. (4171.TWO) stock trades at $17.00 with a market capitalization of $1.13B. The stock is valued at a negative price-to-earnings (P/E) ratio of -26.12, reflecting a net loss over the last twelve months, price-to-book of 1.97, price-to-sales of 4.74. Over the past 52 weeks the stock has ranged between $16.05 and $26.90, and currently trades 36.8% below its 52-week high.
On profitability, GeneReach Biotechnology Corp. generates a return on equity (ROE) of -7.60% (negative, reflecting a net loss), an operating margin of -14.08%, a net profit margin of -18.10%.
Official website: www.genereach.com
GeneReach Biotechnology Corp. (4171.TWO) — frequently asked questions
What is GeneReach Biotechnology Corp. (4171.TWO) stock price today?
GeneReach Biotechnology Corp. (4171.TWO) is currently trading at $17.00, down 0.87% today.
What is 4171.TWO P/E ratio?
GeneReach Biotechnology Corp.'s P/E ratio is -26.12. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 4171.TWO return on equity (ROE)?
GeneReach Biotechnology Corp.'s return on equity (ROE) is -7.60%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is GeneReach Biotechnology Corp.'s market cap?
GeneReach Biotechnology Corp. has a market capitalization of $1.13B.
Does 4171.TWO pay a dividend?
GeneReach Biotechnology Corp. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 4171.TWO carry?
GeneReach Biotechnology Corp. has a debt-to-equity ratio of 0.37. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4171.TWO's profit margin?
GeneReach Biotechnology Corp. reports a net profit margin of -18.10% — the share of revenue left after every cost, including tax and interest.
What sector is 4171.TWO in?
GeneReach Biotechnology Corp. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4171.TWO listed on?
GeneReach Biotechnology Corp. trades on TWO under the ticker 4171.TWO.
What is 4171.TWO's 52-week range?
Over the last year GeneReach Biotechnology Corp. has traded between $16.05 and $26.90.
Related — Stocks
Popular Stocks
Screens 4171.TWO currently matches
On the figures above, GeneReach Biotechnology Corp. passes the filters for 6 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.